Tuesday, February 15, 2022

1:00 PM to 2:00 PM Eastern Time
12:00 PM to 1:00 PM Central Time
11:00 AM to 12:00 PM Mountain Time
10:00 AM to 11:00 PM Pacific Time

 

 

Speaker

David Miklos, MD, PhD
Chief, BMT and Cell Therapy Division
Professor of Medicine
Stanford University
Stanford, CA

 

 

 

 

Speaker

Surbhi Sidana, MD
Assistant Professor of Medicine 
Director, Myeloma Cellular Immunotherapy
Division of BMT & Cell Therapy
Stanford University 
Stanford, CA

We invite you to learn more about:

  • CAR T-cell (chimeric antigen receptor T-cell) therapy for blood cancer patients
  • Who may benefit from CAR T-cell therapy
  • Approved and emerging CAR T-cell therapies
  • The future of CAR T-cell therapy for blood cancer patients


Healthcare professionals are invited to participate. No Continuing Education Credits are offered for this program.

 

Follow LLS